Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

Leistungen

Report on Communication activities carried out

List of press releases to local and national press publication on news about the project

Report on Dissemination activities carried out

List of publications of nonconfidential results

Training reports including core scientific training and transferable skills

Description of planed scientific training and transferable skills to be carried out during the project.

Scaffold hopping and database report

Results using 3D pharmacophores programs

Report on VIRO-FLOW Schools

Description of VIROFLOW Schools and actions performed

Annual update of the training plan per ESR

Veröffentlichungen

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators

Autoren: Tamás Vermes, Mark Kielpinski, Thomas Henkel, Miquel A. Pericàs, Esther Alza, Angelica Corcuera, Helmut Buschmann, Thomas Goldner and Andreas Urban
Veröffentlicht in: Analytical Methods, Ausgabe 14, 2022, Seite(n) 135-146, ISSN 1759-9660
Herausgeber: Royal Society of Chemistry
DOI: 10.1039/d1ay01227d

Rechte des geistigen Eigentums

NOVEL INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Antrags-/Publikationsnummer: 20 20061946
Datum: 2020-04-29
Antragsteller: AICURIS ANTI-INFECTIVE CURES AG

NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Antrags-/Publikationsnummer: 20 20061946
Datum: 2020-04-29
Antragsteller: AICURIS ANTI-INFECTIVE CURES AG

Leistungen

Veröffentlichungen

Rechte des geistigen Eigentums

Diese Seite teilen

Herunterladen